AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROKIDNEY CORP. Director's Dealing 2024

Sep 5, 2024

32485_dirs_2024-09-04_db31d917-3c2c-4cc7-aecd-bfa70c892e20.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2024-09-03

Reporting Person: Fox Jennifer A. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-03	Director stock option (right to buy)	$2.4	A	9535	Acquired	2034-09-03	Class A Ordinary Shares (9535)	Direct

Footnotes

F1: The option shall vest and become exercisable on July 11, 2025 subject to Ms. Fox's continued service with the Company through the applicable vesting date.